NCI-Funded Clinical Research In Jeopardy, ASCO Focuses on Value of NCTN Groups

CHICAGO—The consequences of diminishing federal support for cancer research can be measured in the abstracts presented at the 50th annual meeting of the American Society of Clinical Oncology that concluded earlier this week.

NCI-Funded Clinical Research In Jeopardy, ASCO Focuses on Value of NCTN Groups 2

Hudis's Address at ASCO 2014: On Value & Commitment

NIH to Drop "Alternative From Center's Name; Integrative Better Describes Current Focus

By Tessa Vellek

Kansas City Clinic Settles Medicare Overbilling Claims

By Tessa Vellek

Free

Eddie Reed, 60, A Developer of Taxol

By Otis W. Brawley

In Brief

Georgetown, John Theurer Form Immunotherapy Research Collaboration

John Hopkins to Develop Bladder Cancer Institute

Maurie Markman Named President of CTCA Medicine & Science Unit

UT San Antonio Researchers Call for More Hispanic Enrollment in Trials

The National Patient Advocate Foundation Launches Project Innovation

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues